Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIOGEN | 19 | 54 | -3,97 % | ||
| APELLIS PHARMACEUTICALS | 17 | 4 | +133,40 % | ||
| CENTESSA PHARMACEUTICALS | 8 | - | +39,67 % | ||
| GILEAD SCIENCES | 6 | 5 | +1,76 % | ||
| ZYMEWORKS | 6 | 5 | -1,89 % | ||
| ORIC PHARMACEUTICALS | 6 | 2 | -38,32 % | ||
| AXSOME THERAPEUTICS | 6 | 1 | +6,28 % | ||
| BIONTECH | 4 | 13 | +4,04 % | ||
| ARDELYX | 4 | 8 | +10,35 % | ||
| ARCELLX | 4 | 2 | -0,07 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Biogen, on the heels of a $5.6B buyout, turns its sights to early-stage assets | 4 | BioPharma Dive | ||
| Mi | Beam Therapeutics publishes sickle cell therapy trial data | 1 | Investing.com | ||
| Mi | Gilead cancels midstage HIV trial as FDA's clinical hold remains intact | 2 | FierceBiotech | ||
| Mi | Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine | 1 | GlobeNewswire (USA) | ||
| Mi | Vor Biopharma: Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 2 | GlobeNewswire (USA) | ||
| Mi | Gilead extends Arcellx tender offer deadline to April 24 | 7 | Investing.com | ||
| Mi | Gilead extends Arcellx tender offer expiration date | 2 | Seeking Alpha | ||
| Mi | Gilead verlängert Übernahmeangebot für Arcellx bis zum 24. April | 3 | Investing.com Deutsch | ||
| Mi | Jazz Pharmaceuticals plc: Jazz Pharmaceuticals to Participate in Needham Virtual Healthcare Conference | 173 | PR Newswire | DUBLIN, April 1, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 25th Annual Needham Healthcare Conference. Company management... ► Artikel lesen | |
| Mi | EQS-News: ABIVAX: Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies | 204 | EQS Group (EN) | EQS-News: ABIVAX
/ Key word(s): Miscellaneous
Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
01.04.2026 / 22:05 CET/CEST
The... ► Artikel lesen | |
| Mi | Grail partnering with Superpower to offer Galleri cancer early detection test | 1 | Seeking Alpha | ||
| Mi | Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons | 4 | GlobeNewswire (USA) | ||
| Mi | Design Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Mi | Wolfe Research bestätigt "Peerperform"-Rating für ORIC Pharmaceuticals | 2 | Investing.com Deutsch | ||
| Mi | Wolfe Research reiterates Peerperform on ORIC Pharmaceuticals stock | 1 | Investing.com | ||
| Mi | What's Going On With Structure Therapeutics Stock On Wednesday? | 2 | Benzinga.com | ||
| Mi | Omeros rises as Novo deal boosts Q4 earnings | 20 | Seeking Alpha | ||
| Mi | Pfizer, BioNTech Hit Pause On COVID Shot Trial As Enrollment Falls Flat | 31 | Benzinga.com | ||
| Mi | Jefferies erhöht Kursziel für Scholar Rock nach erneuter Einreichung des Zulassungsantrags | - | Investing.com Deutsch | ||
| Mi | Wolfe Research bestätigt "Peerperform" für Madrigal - M&A-Fantasie treibt Aktie | 9 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.